Europe Defibrillator Market is expected to reach US$ 3,705.85 Million by 2028


PRESS RELEASE BY The Insight Partners 30 Sep 2021

Share this press on


Implantable Cardioverter Defibrillator (ICD) Product to Hold Largest Share of Europe Defibrillator Market During 2021–2028

According to our new research study on “Europe Defibrillator Market Forecast to 2028 – COVID-19 Impact and Country Analysis – by Product and End User,” the market is expected to reach US$ 3,705.85 million by 2028 from US$ 2,692.93 million in 2021; it is estimated to grow at a CAGR of 4.7% during 2021–2028. The report highlights trends prevailing in the market and factors driving its growth. The market growth is mainly attributed to the factors such as increasing prevalence of cardiovascular diseases (CVDs) and rising training and awareness programs on cardiopulmonary resuscitation (CPR) and automated external defibrillators (AEDs). However, product recalls are likely to impact market growth negatively.  

Based on product, the Europe defibrillator market is further segmented into implantable cardioverter defibrillator and external. In 2021, the implantable cardioverter defibrillator segment accounted for a higher market share and is expected to grow at a faster CAGR during the forecast period. The rising demand for ICDs from patients with nonischemic cardiomyopathy has improved survival rates and reduced mortality risk, which is projected to provide opportunities for ICD manufacturers. The ICD segment is further divided into transvenous ICD and subcutaneous ICD.

In terms of end user, the Europe defibrillator market is segmented into hospitals and clinics, prehospital care, public access, home care settings, and alternate care facilities.

Medtronic; Abbott; Boston Scientific Corporation; ZOLL MEDICAL CORPORATION; Koninklijke Philips N.V.; Biotronik; Inc.; CU Medical Systems, Inc.; Progetti srl; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; and Nihon Kohden Corporation are among the leading companies operating in Europe defibrillator market.

Europe Defibrillator Market, by Country, 2021 (%)
Europe Defibrillator Market, by Country, 2021 (%)

Europe Defibrillator Market to Grow at a CAGR of 4.7% to reach US$ 3,705.85 Million from 2021 to 2028

Download Free Sample

Europe Defibrillator Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Implantable Cardioverter Defibrillator and External) and End User (Hospitals and Clinics, Prehospital Care, Public Access, Home Care Settings, and Alternate Care Facilities)


By Country

  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • Netherlands
  • Sweden
  • Austria
  • Norway
  • Denmark
  • Finland
  • Portugal
  • Romania
  • RoE

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

Download Free PDF Brochure